Variant report
Variant | nsv525401 |
---|---|
Chromosome Location | chr1:47318400-47329647 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs34700015 | chr1:47322607-47322608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs35986712 | chr1:47322608-47322609 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs537188442 | chr1:47322615-47322616 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs34865494 | chr1:47322630-47322631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs555450417 | chr1:47322678-47322679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs573922562 | chr1:47322681-47322682 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs541431376 | chr1:47322743-47322744 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs35261373 | chr1:47322767-47322768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs11211385 | chr1:47322775-47322776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs11211386 | chr1:47322833-47322834 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs578216765 | chr1:47322907-47322908 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs113511168 | chr1:47322943-47322944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs141669231 | chr1:47322956-47322957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs531134476 | chr1:47322995-47322996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs56101164 | chr1:47323008-47323009 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
16 | rs370125236 | chr1:47323010-47323011 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs56239161 | chr1:47323026-47323027 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs547405987 | chr1:47323060-47323061 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs559366627 | chr1:47323061-47323062 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs71307623 | chr1:47323063-47323064 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs79222717 | chr1:47323091-47323092 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs533306497 | chr1:47323103-47323104 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs375985036 | chr1:47323122-47323123 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs200199465 | chr1:47323126-47323127 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs532274893 | chr1:47323141-47323142 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs551153694 | chr1:47323142-47323143 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs140487327 | chr1:47323168-47323169 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs191159134 | chr1:47323200-47323201 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs536852379 | chr1:47323201-47323202 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs549031932 | chr1:47323228-47323229 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs567781357 | chr1:47323276-47323277 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs534686730 | chr1:47323277-47323278 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs199731550 | chr1:47323288-47323289 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs34065395 | chr1:47323292-47323293 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs578178935 | chr1:47323295-47323296 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs539296357 | chr1:47323311-47323312 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs11211387 | chr1:47323322-47323323 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs537588065 | chr1:47323323-47323324 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs575876633 | chr1:47323380-47323381 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs184398903 | chr1:47323391-47323392 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs2813859 | chr1:47323423-47323424 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs386630921 | chr1:47323446-47323447 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs2405338 | chr1:47323448-47323449 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs11355255 | chr1:47323450-47323451 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs561614469 | chr1:47323502-47323503 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs145678741 | chr1:47323503-47323504 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs532776180 | chr1:47323528-47323529 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs555341306 | chr1:47323605-47323606 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs2813858 | chr1:47323614-47323615 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs200230588 | chr1:47323619-47323620 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 17603634 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Melanoma | 17363583 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Muscle-eye-brain disease | 21572526 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Glioblastoma | 20031968 | CNVD |
Leukemia | 18688285 | CNVD |
Rett syndrome | 21593744 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:47322600-47324000 | Enhancers | NHEK | skin |
2 | chr1:47323000-47323400 | Enhancers | HUVEC | blood vessel |
3 | chr1:47323000-47323600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr1:47323000-47323600 | Enhancers | HMEC | breast |
5 | chr1:47323000-47324000 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
6 | chr1:47323000-47324000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
7 | chr1:47323200-47323600 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
8 | chr1:47323200-47323800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
9 | chr1:47323200-47324000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
10 | chr1:47323200-47324400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
11 | chr1:47323400-47325000 | Weak transcription | Left Ventricle | heart |
12 | chr1:47323600-47323800 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
13 | chr1:47324000-47324400 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
14 | chr1:47324400-47325000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
15 | chr1:47324800-47325200 | ZNF genes & repeats | Esophagus | oesophagus |
16 | chr1:47325000-47325200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
17 | chr1:47325200-47327600 | Weak transcription | Esophagus | oesophagus |
18 | chr1:47326600-47326800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |